Lv1
38 积分 2024-05-02 加入
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
1个月前
已完结
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
4个月前
已完结
APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration
5个月前
已完结
The Rise of Drug Innovation in China — Implications for Patient Access in the United States and Globally
7个月前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
8个月前
已完结
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary
10个月前
已完结
ERα dysfunction caused by ESR1 mutations and therapeutic pressure promotes lineage plasticity in ER+ breast cancer
11个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
1年前
已完结
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
1年前
已完结
Psoriasis
1年前
已完结
皖公网安备34019202002308
